BioCentury | Feb 23, 2015
Financial News

Lifecode completes venture financing

Lifecode Inc. , Foster City, Calif. Business: Diagnostic, Genomics Date completed: 2015-02-19 Type: Venture financing Raised: $20.5 million Investors: Sequoia Capital; Mayo Clinic WIR Staff Diagnostic...
BioCentury | Feb 20, 2015
Financial News

Lifecode raises $20.5M series A round

...Molecular diagnostics company Lifecode Inc. (Foster City, Calif.) raised $20.5 million in a series A funding led...
...Clinic ; and Mayo Ventures. The company did not respond to a request for details. Lifecode...
BioCentury | Jun 16, 2014
Company News

Immucor, Organ-i deal

Immucor acquired Organ-i, which develops non-invasive tests to monitor and predict organ health for transplant recipients. Immucor declined to disclose financial terms but said the deal strengthens its presence in transplantation diagnostics. The company said...
BioCentury | Apr 1, 2013
Company News

Hologic, Immucor deal

Immucor completed the acquisition of Hologic's Lifecodes business unit. Hologic acquired Lifecodes through its 2012 acquisition of Gen-Probe Inc. (see BioCentury, Aug. 6, 2012 & Jan. 14, 2013). Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Immucor Inc....
BioCentury | Jan 14, 2013
Company News

Hologic, Immucor deal

Hologic will sell its Lifecodes business unit to Immucor for $85 million in cash and up to $10 million contingent on achievement of certain financial targets in 2013. Lifecodes sells molecular- and antibody-based assays for...
BioCentury | Jan 3, 2011
Company News

Gen-Probe, GTI Diagnostics deal

Gen-Probe acquired GTI from private equity firm Riverside Co. for $53 million in cash. GTI provides the human leukocyte antigen (HLA) antibody detection products sold by Gen-Probe as Lifecodes HLA kits. The company also sells...
BioCentury | Feb 2, 2009
Company News

Gen-Probe, Tepnel deal

Gen-Probe will acquire diagnostic company Tepnel for 27.1p per share, or about £92.8 million ($127.2 million) in cash. The price is a 32% premium to Tepnel's close of 20.5p Jan. 29, the day before the...
BioCentury | Jan 31, 2009
Company News

Gen-Probe to acquire Tepnel

Gen-Probe (NASDAQ:GPRO) will acquire fellow diagnostics company Tepnel (LSE:TED) for 27.1p per share, or about L92.8 million ($127.2 million) in cash. The price represents a 126% percent premium to Tepnel's close of 12p on Jan....
BioCentury | Jul 14, 2003
Company News

Matritech board of directors update

Matritech Inc. (NMPS), Newton, Mass. Business: Diagnostics/Imaging Appointed: Walter Fredericks, former president and CEO of Lifecodes Corp. WIR Staff Diagnostic...
BioCentury | Dec 10, 2001
Company News

Orchid, Lifecodes Corp. deal

ORCH completed its previously announced acquisition of Lifecodes, a developer of identity genomics testing for forensics and paternity (see BioCentury, Oct. 8). Orchid BioSciences Inc. (ORCH), Princeton, N.J. Lifecodes Corp. , Stamford, Conn. Business: Pharmacogenetics WIR...
Items per page:
1 - 10 of 18
BioCentury | Feb 23, 2015
Financial News

Lifecode completes venture financing

Lifecode Inc. , Foster City, Calif. Business: Diagnostic, Genomics Date completed: 2015-02-19 Type: Venture financing Raised: $20.5 million Investors: Sequoia Capital; Mayo Clinic WIR Staff Diagnostic...
BioCentury | Feb 20, 2015
Financial News

Lifecode raises $20.5M series A round

...Molecular diagnostics company Lifecode Inc. (Foster City, Calif.) raised $20.5 million in a series A funding led...
...Clinic ; and Mayo Ventures. The company did not respond to a request for details. Lifecode...
BioCentury | Jun 16, 2014
Company News

Immucor, Organ-i deal

Immucor acquired Organ-i, which develops non-invasive tests to monitor and predict organ health for transplant recipients. Immucor declined to disclose financial terms but said the deal strengthens its presence in transplantation diagnostics. The company said...
BioCentury | Apr 1, 2013
Company News

Hologic, Immucor deal

Immucor completed the acquisition of Hologic's Lifecodes business unit. Hologic acquired Lifecodes through its 2012 acquisition of Gen-Probe Inc. (see BioCentury, Aug. 6, 2012 & Jan. 14, 2013). Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Immucor Inc....
BioCentury | Jan 14, 2013
Company News

Hologic, Immucor deal

Hologic will sell its Lifecodes business unit to Immucor for $85 million in cash and up to $10 million contingent on achievement of certain financial targets in 2013. Lifecodes sells molecular- and antibody-based assays for...
BioCentury | Jan 3, 2011
Company News

Gen-Probe, GTI Diagnostics deal

Gen-Probe acquired GTI from private equity firm Riverside Co. for $53 million in cash. GTI provides the human leukocyte antigen (HLA) antibody detection products sold by Gen-Probe as Lifecodes HLA kits. The company also sells...
BioCentury | Feb 2, 2009
Company News

Gen-Probe, Tepnel deal

Gen-Probe will acquire diagnostic company Tepnel for 27.1p per share, or about £92.8 million ($127.2 million) in cash. The price is a 32% premium to Tepnel's close of 20.5p Jan. 29, the day before the...
BioCentury | Jan 31, 2009
Company News

Gen-Probe to acquire Tepnel

Gen-Probe (NASDAQ:GPRO) will acquire fellow diagnostics company Tepnel (LSE:TED) for 27.1p per share, or about L92.8 million ($127.2 million) in cash. The price represents a 126% percent premium to Tepnel's close of 12p on Jan....
BioCentury | Jul 14, 2003
Company News

Matritech board of directors update

Matritech Inc. (NMPS), Newton, Mass. Business: Diagnostics/Imaging Appointed: Walter Fredericks, former president and CEO of Lifecodes Corp. WIR Staff Diagnostic...
BioCentury | Dec 10, 2001
Company News

Orchid, Lifecodes Corp. deal

ORCH completed its previously announced acquisition of Lifecodes, a developer of identity genomics testing for forensics and paternity (see BioCentury, Oct. 8). Orchid BioSciences Inc. (ORCH), Princeton, N.J. Lifecodes Corp. , Stamford, Conn. Business: Pharmacogenetics WIR...
Items per page:
1 - 10 of 18